BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25062112)

  • 1. Significantly increased CD70 up regulation on TEL-AML positive B cell precursor acute lymphoblastic leukemia cells following CD40 stimulation.
    Troeger A; Glouchkova L; Ackermann B; Escherich G; Hanenberg H; Janka G; Roettgers S; Göbel U; Dilloo D
    Klin Padiatr; 2014 Nov; 226(6-7):332-7. PubMed ID: 25062112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression and defective modulation of TNF receptor/ligand family molecules on proB-ALL blasts.
    Troeger A; Glouchkova L; Escherich G; Siepermann M; Hanenberg H; Janka-Schaub G; Göbel U; Ackermann B; Dilloo D
    Klin Padiatr; 2008; 220(6):353-7. PubMed ID: 18949670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of CD40 on B-cell precursor acute lymphoblastic leukemia blasts is an independent risk factor associated with improved survival and enhanced capacity to up-regulate the death receptor CD95.
    Troeger A; Glouchkova L; Ackermann B; Escherich G; Meisel R; Hanenberg H; den Boer ML; Pieters R; Janka-Schaub GE; Goebel U; Laws HJ; Dilloo D
    Blood; 2008 Aug; 112(4):1028-34. PubMed ID: 18552209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETV6 (TEL)-AML1 pre-B acute lymphoblastic leukaemia cells are associated with a distinct antigen-presenting phenotype.
    Alessandri AJ; Reid GS; Bader SA; Massing BG; Sorensen PH; Schultz KR
    Br J Haematol; 2002 Feb; 116(2):266-72. PubMed ID: 11841426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Tel-Aml1 transcript variants in pediatric acute lymphoblastic leukemia.
    Kustanovich AM; Belevtsev MV; Stasevich IV; Savitskaya TV; Jutzkevich RI; Savva NN; Aleinikova OV
    Leukemia; 2006 Jan; 20(1):165-7. PubMed ID: 16307024
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospective analysis of TEL gene rearrangements in childhood acute lymphoblastic leukemia: a Children's Oncology Group study.
    Rubnitz JE; Wichlan D; Devidas M; Shuster J; Linda SB; Kurtzberg J; Bell B; Hunger SP; Chauvenet A; Pui CH; Camitta B; Pullen J;
    J Clin Oncol; 2008 May; 26(13):2186-91. PubMed ID: 18445843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia.
    Sabaawy HE; Azuma M; Embree LJ; Tsai HJ; Starost MF; Hickstein DD
    Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15166-71. PubMed ID: 17015828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CD70/CD27 pathway is critical for stimulation of an effective cytotoxic T cell response against B cell precursor acute lymphoblastic leukemia.
    Glouchkova L; Ackermann B; Zibert A; Meisel R; Siepermann M; Janka-Schaub GE; Goebel U; Troeger A; Dilloo D
    J Immunol; 2009 Jan; 182(1):718-25. PubMed ID: 19109206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
    Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
    Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interphase FISH on TEL/AML1 positive acute lymphoblastic leukemia relapses--analysis of clinical relevance of additional TEL and AML1 copy number changes.
    Peter A; Heiden T; Taube T; Körner G; Seeger K
    Eur J Haematol; 2009 Nov; 83(5):420-32. PubMed ID: 19594616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01.
    Loh ML; Goldwasser MA; Silverman LB; Poon WM; Vattikuti S; Cardoso A; Neuberg DS; Shannon KM; Sallan SE; Gilliland DG
    Blood; 2006 Jun; 107(11):4508-13. PubMed ID: 16493009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor-acute lymphoblastic leukaemia.
    Troeger A; Gudowius S; Escherich G; den Boer ML; Glouchkova L; Ackermann B; Meisel R; Laws HJ; Groeger M; Wessalowski R; Willers R; Harbott J; Pieters R; Goebel U; Janka-Schaub GE; Hanenberg H; Dilloo D
    Br J Haematol; 2007 Nov; 139(3):450-7. PubMed ID: 17910636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics of children with B cell type acute lymphoblastic leukemia carrying different fusion gene].
    Zuo YX; Zhang LP; Lu AD; Wang B; Liu GL
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Mar; 12(3):172-6. PubMed ID: 20350423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD27-CD70 on early B cell progenitors in the bone marrow: implication for diagnosis and therapy of childhood ALL.
    Nilsson A; de Milito A; Mowafi F; Winberg G; Björk O; Wolpert EZ; Chiodi F
    Exp Hematol; 2005 Dec; 33(12):1500-7. PubMed ID: 16338493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TEL/AML-1 fusion gene. its frequency and prognostic significance in childhood acute lymphoblastic leukemia.
    Jamil A; Theil KS; Kahwash S; Ruymann FB; Klopfenstein KJ
    Cancer Genet Cytogenet; 2000 Oct; 122(2):73-8. PubMed ID: 11106814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.
    Mosad E; Hamed HB; Bakry RM; Ezz-Eldin AM; Khalifa NM
    J Hematol Oncol; 2008 Oct; 1():17. PubMed ID: 18928518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel TEL-AML1 fusion transcript involving the pro-apoptotic gene BCL-G in pediatric precursor B acute lymphoblastic leukemia.
    Abdelhaleem M; Yi Q; Beimnet K; Hitzler J
    Leukemia; 2006 Jul; 20(7):1294. PubMed ID: 16673018
    [No Abstract]   [Full Text] [Related]  

  • 18. High expression of cytoskeletal protein drebrin in TEL/AML1pos B-cell precursor acute lymphoblastic leukemia identified by a novel monoclonal antibody.
    Vaskova M; Kovac M; Volna P; Angelisova P; Mejstrikova E; Zuna J; Brdicka T; Hrusak O
    Leuk Res; 2011 Aug; 35(8):1111-3. PubMed ID: 21497902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection.
    Panzer-Grümayer ER; Cazzaniga G; van der Velden VH; del Giudice L; Peham M; Mann G; Eckert C; Schrauder A; Germano G; Harbott J; Basso G; Biondi A; van Dongen JJ; Gadner H; Haas OA
    Clin Cancer Res; 2005 Nov; 11(21):7720-7. PubMed ID: 16278392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD9 expression can be used to predict childhood TEL/AML1-positive acute lymphoblastic leukemia: proposal for an accelerated diagnostic flowchart.
    Gandemer V; Aubry M; Roussel M; Rio AG; de Tayrac M; Vallee A; Mosser J; Ly-Sunnaram B; Galibert MD
    Leuk Res; 2010 Apr; 34(4):430-7. PubMed ID: 19896186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.